20 Drugmakers Must Face Generic Price-Fixing MDL
A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article